Multiple Interferon Regulatory Factor and NF-κB Sites Cooperate in Mediating Cell-Type- and Maturation-Specific Activation of the Human CD83 Promoter in Dendritic Cells

REFERENCES

• Banchereau J, Steinman RM. 1998. Dendritic cells and the control of immunity. Nature 392:245–252.
   PubMed Web of Science ®Google Scholar
• Zhou LJ, Tedder TF. 1996. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 93:2588–2592.
   PubMed Web of Science ®Google Scholar
• Prechtel AT, Steinkasserer A. 2007. CD83: an update on functions and prospects of the maturation marker of dendritic cells. Arch. Dermatol. Res. 299:59–69.
   PubMed Web of Science ®Google Scholar
• Kruse M, Rosorius O, Kratzer F, Bevec D, Kuhnt C, Steinkasserer A, Schuler G, Hauber J. 2000. Inhibition of CD83 cell surface expression during dendritic cell maturation by interference with nuclear export of CD83 mRNA. J. Exp. Med. 191:1581–1590.
   PubMedGoogle Scholar
• Aerts-Toegaert C, Heirman C, Tuyaerts S, Corthals J, Aerts JL, Bonehill A, Thielemans K, Breckpot K. 2007. CD83 expression on dendritic cells and T cells: correlation with effective immune responses. Eur. J. Immunol. 37:686–695.
   PubMed Web of Science ®Google Scholar
• Prechtel AT, Turza NM, Theodoridis AA, Steinkasserer A. 2007. CD83 knockdown in monocyte-derived dendritic cells by small interfering RNA leads to a diminished T cell stimulation. J. Immunol. 178:5454–5464.
   PubMedGoogle Scholar
• Prazma CM, Yazawa N, Fujimoto Y, Fujimoto M, Tedder TF. 2007. CD83 expression is a sensitive marker of activation required for B cell and CD4+ T cell longevity in vivo. J. Immunol. 179:4550–4562.
   PubMedGoogle Scholar
• Lechmann M, Krooshoop DJ, Dudziak D, Kremmer E, Kuhnt C, Figdor CG, Schuler G, Steinkasserer A. 2001. The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells. J. Exp. Med. 194:1813–1821.
   PubMed Web of Science ®Google Scholar
• Scholler N, Hayden-Ledbetter M, Dahlin A, Hellstrom I, Hellstrom KE, Ledbetter JA. 2002. CD83 regulates the development of cellular immunity. J. Immunol. 168:2599–2602.
   PubMedGoogle Scholar
• Zinser E, Lechmann M, Golka A, Lutz MB, Steinkasserer A. 2004. Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83. J. Exp. Med. 200:345–351.
   PubMedGoogle Scholar
• Ge W, Arp J, Lian D, Liu W, Baroja ML, Jiang J, Ramcharran S, Eldeen FZ, Zinser E, Steinkasserer A, Chou P, Brand S, Nicolette C, Garcia B, Wang H. 2010. Immunosuppression involving soluble CD83 induces tolerogenic dendritic cells that prevent cardiac allograft rejection. Transplantation 90:1145–1156.
   PubMedGoogle Scholar
• Lan Z, Lian D, Liu W, Arp J, Charlton B, Ge W, Brand S, Healey D, DeBenedette M, Nicolette C, Garcia B, Wang H. 2010. Prevention of chronic renal allograft rejection by soluble CD83. Transplantation 90:1278–1285.
   PubMedGoogle Scholar
• Berchtold S, Muhl-Zurbes P, Maczek E, Golka A, Schuler G, Steinkasserer A. 2002. Cloning and characterization of the promoter region of the human CD83 gene. Immunobiology 205:231–246.
   PubMedGoogle Scholar
• Maston GA, Evans SK, Green MR. 2006. Transcriptional regulatory elements in the human genome. Annu. Rev. Genomics Hum. Genet. 7:29–59.
   PubMed Web of Science ®Google Scholar
• Lefstin JA, Yamamoto KR. 1998. Allosteric effects of DNA on transcriptional regulators. Nature 392:885–888.
   PubMed Web of Science ®Google Scholar
• Remenyi A, Scholer HR, Wilmanns M. 2004. Combinatorial control of gene expression. Nat. Struct. Mol. Biol. 11:812–815.
   PubMedGoogle Scholar
• Cohen CD, Klingenhoff A, Boucherot A, Nitsche A, Henger A, Brunner B, Schmid H, Merkle M, Saleem MA, Koller KP, Werner T, Grone HJ, Nelson PJ, Kretzler M. 2006. Comparative promoter analysis allows de novo identification of specialized cell junction-associated proteins. Proc. Natl. Acad. Sci. U. S. A. 103:5682–5687.
   PubMedGoogle Scholar
• Knippertz I, Hesse A, Schunder T, Kampgen E, Brenner MK, Schuler G, Steinkasserer A, Nettelbeck DM. 2009. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma. J. Immunother. 32:524–538.
   PubMedGoogle Scholar
• Schaft N, Dorrie J, Muller I, Beck V, Baumann S, Schunder T, Kampgen E, Schuler G. 2006. A new way to generate cytolytic tumor-specific T cells: electroporation of RNA coding for a T cell receptor into T lymphocytes. Cancer Immunol. Immunother. 55:1132–1141.
   PubMed Web of Science ®Google Scholar
• Rohmer S, Mainka A, Knippertz I, Hesse A, Nettelbeck DM. 2008. Insulated hsp70B′ promoter: stringent heat-inducible activity in replication-deficient, but not replication-competent adenoviruses. J. Gene Med. 10:340–354.
   PubMed Web of Science ®Google Scholar
• Naschberger E, Werner T, Vicente AB, Guenzi E, Topolt K, Leubert R, Lubeseder-Martellato C, Nelson PJ, Sturzl M. 2004. Nuclear factor-kappaB motif and interferon-alpha-stimulated response element co-operate in the activation of guanylate-binding protein-1 expression by inflammatory cytokines in endothelial cells. Biochem. J. 379:409–420.
   PubMedGoogle Scholar
• Milne TA, Zhao K, Hess JL. 2009. Chromatin immunoprecipitation (ChIP) for analysis of histone modifications and chromatin-associated proteins. Methods Mol. Biol. 538:409–423.
   PubMedGoogle Scholar
• McCurdy RD, McGrath JJ, Mackay-Sim A. 2008. Validation of the comparative quantification method of real-time PCR analysis and a cautionary tale of housekeeping gene selection. Gene Ther. Mol. Biol. 12:15–24.
   Google Scholar
• Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP. 2004. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper-Excel-based tool using pair-wise correlations. Biotechnol. Lett. 26:509–515.
   PubMed Web of Science ®Google Scholar
• Nencioni A, Beck J, Werth D, Grunebach F, Patrone F, Ballestrero A, Brossart P. 2007. Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity. Clin. Cancer Res. 13:3933–3941.
   PubMed Web of Science ®Google Scholar
• Tamura T, Yanai H, Savitsky D, Taniguchi T. 2008. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26:535–584.
   PubMed Web of Science ®Google Scholar
• Bros M, Ross XL, Pautz A, Reske-Kunz AB, Ross R. 2003. The human fascin gene promoter is highly active in mature dendritic cells due to a stage-specific enhancer. J. Immunol. 171:1825–1834.
   PubMedGoogle Scholar
• Mosialos G, Yamashiro S, Baughman RW, Matsudaira P, Vara L, Matsumura F, Kieff E, Birkenbach M. 1994. Epstein-Barr virus infection induces expression in B lymphocytes of a novel gene encoding an evolutionarily conserved 55-kilodalton actin-bundling protein. J. Virol. 68:7320–7328.
   PubMedGoogle Scholar
• Pinkus GS, Pinkus JL, Langhoff E, Matsumura F, Yamashiro S, Mosialos G, Said JW. 1997. Fascin, a sensitive new marker for Reed-Sternberg cells of Hodgkin's disease. Evidence for a dendritic or B cell derivation?. Am. J. Pathol. 150:543–562.
   PubMed Web of Science ®Google Scholar
• Hashimoto Y, Skacel M, Adams JC. 2005. Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker? Int. J. Biochem. Cell Biol. 37:1787–1804.
   PubMed Web of Science ®Google Scholar
• Hashimoto Y, Loftis DW, Adams JC. 2009. Fascin-1 promoter activity is regulated by CREB and the aryl hydrocarbon receptor in human carcinoma cells. PLoS One 4:e5130. doi:10.1371/journal.pone.0005130.
   Google Scholar
• Kawai T, Akira S. 2006. TLR signaling. Cell Death Differ. 13:816–825.
   PubMed Web of Science ®Google Scholar
• Krausgruber T, Saliba D, Ryzhakov G, Lanfrancotti A, Blazek K, Udalova IA. 2010. IRF5 is required for late-phase TNF secretion by human dendritic cells. Blood 115:4421–4430.
   PubMedGoogle Scholar
• McKinsey TA, Chu Z, Tedder TF, Ballard DW. 2000. Transcription factor NF-kappaB regulates inducible CD83 gene expression in activated T lymphocytes. Mol. Immunol. 37:783–788.
   PubMedGoogle Scholar
• Barnes BJ, Kellum MJ, Field AE, Pitha PM. 2002. Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes. Mol. Cell. Biol. 22:5721–5740.
   PubMed Web of Science ®Google Scholar
• Mancl ME, Hu G, Sangster-Guity N, Olshalsky SL, Hoops K, Fitzgerald-Bocarsly P, Pitha PM, Pinder K, Barnes BJ. 2005. Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms. Multiple isoforms with distinct cell type-specific expression, localization, regulation, and function. J. Biol. Chem. 280:21078–21090.
   PubMed Web of Science ®Google Scholar
• Takaoka A, Yanai H, Kondo S, Duncan G, Negishi H, Mizutani T, Kano S, Honda K, Ohba Y, Mak TW, Taniguchi T. 2005. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434:243–249.
   PubMed Web of Science ®Google Scholar
• Krausgruber T, Blazek K, Smallie T, Alzabin S, Lockstone H, Sahgal N, Hussell T, Feldmann M, Udalova IA. 2011. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat. Immunol. 12:231–238.
   PubMed Web of Science ®Google Scholar
• Battistini A. 2009. Interferon regulatory factors in hematopoietic cell differentiation and immune regulation. J. Interferon Cytokine Res. 29:765–780.
   PubMed Web of Science ®Google Scholar
• Huang B, Qi ZT, Xu Z, Nie P. 2010. Global characterization of interferon regulatory factor (IRF) genes in vertebrates: glimpse of the diversification in evolution. BMC Immunol. 11:22. doi:10.1186/1471-2172-11-22.
   Google Scholar
• Tailor P, Tamura T, Ozato K. 2006. IRF family proteins and type I interferon induction in dendritic cells. Cell Res. 16:134–140.
   PubMed Web of Science ®Google Scholar
• Harada H, Fujita T, Miyamoto M, Kimura Y, Maruyama M, Furia A, Miyata T, Taniguchi T. 1989. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58:729–739.
   PubMed Web of Science ®Google Scholar
• Taniguchi T. 1995. IRF-1 and IRF-2 as regulators of the interferon system and cell growth. Indian J. Biochem. Biophys. 32:235–239.
   PubMed Web of Science ®Google Scholar
• Taniguchi T, Ogasawara K, Takaoka A, Tanaka N. 2001. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19:623–655.
   PubMed Web of Science ®Google Scholar
• Masumi A. 2011. Histone acetyltransferases as regulators of nonhistone proteins: the role of interferon regulatory factor acetylation on gene transcription. J. Biomed. Biotechnol. 2011:640610. doi:10.1155/2011/640610.
   Google Scholar
• Masumi A, Ozato K. 2001. Coactivator p300 acetylates the interferon regulatory factor-2 in U937 cells following phorbol ester treatment. J. Biol. Chem. 276:20973–20980.
   PubMed Web of Science ®Google Scholar
• Marsili G, Remoli AL, Sgarbanti M, Battistini A. 2004. Role of acetylases and deacetylase inhibitors in IRF-1-mediated HIV-1 long terminal repeat transcription. Ann. N. Y. Acad. Sci. 1030:636–643.
   PubMed Web of Science ®Google Scholar
• Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T. 2005. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21:2933–2942.
   PubMed Web of Science ®Google Scholar
• Ouyang X, Negishi H, Takeda R, Fujita Y, Taniguchi T, Honda K. 2007. Cooperation between MyD88 and TRIF pathways in TLR synergy via IRF5 activation. Biochem. Biophys. Res. Commun. 354:1045–1051.
   PubMed Web of Science ®Google Scholar
• Cope NF, Fraser P, Eskiw CH. 2010. The yin and yang of chromatin spatial organization. Genome Biol. 11:204. doi:10.1186/gb-2010-11-3-204.
   Google Scholar
• Saiz L, Vilar JM. 2006. DNA looping: the consequences and its control. Curr. Opin. Struct. Biol. 16:344–350.
   PubMedGoogle Scholar
• Johnson S, Linden M, Phillips R. 2012. Sequence dependence of transcription factor-mediated DNA looping. Nucleic Acids Res. 40:7728–7738.
   PubMed Web of Science ®Google Scholar
• Werner T. 2010. Next generation sequencing in functional genomics. Brief. Bioinform. 11:499–511.
   PubMed Web of Science ®Google Scholar
• Johnson DR, Pober JS. 1994. HLA class I heavy-chain gene promoter elements mediating synergy between tumor necrosis factor and interferons. Mol. Cell. Biol. 14:1322–1332.
   PubMed Web of Science ®Google Scholar
• Ohmori Y, Hamilton TA. 1995. The interferon-stimulated response element and a kappa B site mediate synergistic induction of murine IP-10 gene transcription by IFN-gamma and TNF-alpha. J. Immunol. 154:5235–5244.
   PubMed Web of Science ®Google Scholar